glp-1 eye issues GLP 1 Blindness Risk GLP-1 Receptor Agonists and vision

Adverse psychiatric effects associated with GLP-1 RAs, including depression, anxiety, and suicidal ideation, are noted in pharmacovigilance analyses, with variations among different GLP-1 RAs

Now it might protect your brain

Once Monthly GLP-1 Maridebart cafraglutide is an investigational once-monthly injectable drug developed by Amgen that shows significant promise for treating obesity and Type 2 diabetes

Just finished my latest Costco haul

Understanding how these medications interact with mental health conditions helps you make informed treatment decisions with your healthcare team

As a triple agonist targeting GLP-1, GIP, and glucagon